Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study.

Junxian LiLuyang LiuZiwei FengXin WangYubei HuangHongji DaiLiwen ZhangFangfang SongDezheng WangPengyu ZhangBaoshan MaHaixin LiHong ZhengFengju SongKexin Chen

Published in: Breast cancer (Tokyo, Japan) (2020)

Preoperative CA15-3 and CEA levels differ in breast cancer molecular subtypes and yield strong prognostic information in Chinese women with breast cancer. Measuring CA15-3 and CEA levels before surgery may have the potential in predicting breast cancer survival and offering patients' personalized treatment strategy among luminal A and basal-like subtypes.

Keyphrases

protein kinase
end stage renal disease
ejection fraction
newly diagnosed
minimally invasive
prognostic factors
free survival
healthcare
coronary artery bypass
single molecule
patient reported outcomes
health information
acute coronary syndrome
climate change
combination therapy